Intralesional therapy for advanced melanoma: promise and limitation

por Agarwala, Sanjiv S.
Publicado 2015

Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review

por Agarwala, Sanjiv S., Case, Scott
Publicado 2010

Management of metastatic cutaneous melanoma: updates in clinical practice

por Schvartsman, Gustavo, Taranto, Patricia, Glitza, Isabella C., Agarwala, Sanjiv S., Atkins, Michael B., Buzaid, Antonio C.
Publicado 2019

High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014

por Dutcher, Janice P, Schwartzentruber, Douglas J, Kaufman, Howard L, Agarwala, Sanjiv S, Tarhini, Ahmad A, Lowder, James N, Atkins, Michael B
Publicado 2014

Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma

por Nemunaitis, John J, Linette, Gerald P, Hamid, Omid, Agarwala, Sanjiv S, Starodub, Alexander, Sun, Lei, Lebel, Francois, Barrett, John A, Lewis, Jonathan
Publicado 2014

A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial

por Li, Tianhong, Christensen, Scott D., Frankel, Paul H., Margolin, Kim A., Agarwala, Sanjiv S., Luu, Thehang, Mack, Philip C., Lara, Primo N., Gandara, David R.
Publicado 2010

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

por Tarhini, Ahmad A., Lin, Yan, Zahoor, Haris, Shuai, Yongli, Butterfield, Lisa H., Ringquist, Steven, Gogas, Helen, Sander, Cindy, Lee, Sandra, Agarwala, Sanjiv S., Kirwood, John M.
Publicado 2015

The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019

por Ascierto, Paolo A., Agarwala, Sanjiv S., Eggermont, Alexander, Gershenwald, Jeffrey E., Grob, Jean-Jacques, Hamid, Omid, Michielin, Olivier, Postow, Michael, Puzanov, Igor, Zarour, Hassane M., Caracò, Corrado, Testori, Alessandro
Publicado 2020

Evaluation of the reporting quality of clinical practice guidelines on melanoma using the RIGHT checklist

por Yang, Yongjie, Ma, Yanfang, Lu, Jingli, Zhang, Qiwen, Guan, Kelei, Liu, Kefeng, Kang, Jian, Du, Shuzhang, Tang, Shu, Liu, Xuehui, Zhang, Ailing, Schadendorf, Dirk, Agarwala, Sanjiv S., Zhang, Xiaojian
Publicado 2021

Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma

por Thompson, John F., Agarwala, Sanjiv S., Smithers, B. Mark, Ross, Merrick I., Scoggins, Charles R., Coventry, Brendon J., Neuhaus, Susan J., Minor, David R., Singer, Jamie M., Wachter, Eric A.
Publicado 2014

Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte‐macrophage colony‐stimulating factor for the treatment of unres...

por Andtbacka, Robert H. I., Agarwala, Sanjiv S., Ollila, David W., Hallmeyer, Sigrun, Milhem, Mohammed, Amatruda, Thomas, Nemunaitis, John J., Harrington, Kevin J., Chen, Lisa, Shilkrut, Mark, Ross, Merrick, Kaufman, Howard L.
Publicado 2016

Final planned overall survival (OS) from OPTiM, a randomized Phase III trial of talimogene laherparepvec (T-VEC) versus GM-CSF for the treatment of unresected stage IIIB/C/IV melan...

por Andtbacka, Robert HI, Collichio, Frances A, Amatruda, Thomas, Senzer, Neil, Chesney, Jason, Delman, Keith, Spitler, Lynn, Puzanov, Igor, Agarwala, Sanjiv, Milhem, Mohammed, Harrington, Kevin, Middleton, Mark, Li, Ai, Shilkrut, Mark, Coffin, Robert, Kaufman, Howard
Publicado 2014

A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma

por Clark, Joseph I., Singh, Jatinder, Ernstoff, Marc S., Lao, Christopher D., Flaherty, Lawrence E., Logan, Theodore F., Curti, Brendan, Agarwala, Sanjiv S., Taback, Bret, Cranmer, Lee, Lutzky, Jose, Luna, Theresa L., Aung, Sandra, Lawson, David H.
Publicado 2018

Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma

por Rasco, Drew W., Medina, Theresa, Corrie, Pippa, Pavlick, Anna C., Middleton, Mark R., Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S., Daud, Adil I., Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J.
Publicado 2023

A multi-center study of high dose Aldesleukin (Proleukin(® )(HD IL-2) + Vemurafenib Zelboraf(® )) therapy in patients with BRAF(V600 )mutation positive metastatic melanoma (procliv...

por Clark, Joseph, Flaherty, Lawrence, Ernstoff, Marc, Koon, Henry, Milhem, Mohammed, Militello, Gerald, Agarwala, Sanjiv, Curti, Brendan, Cranmer, Lee, Lao, Christopher D, Logan, Theodore F, Lutzky, Jose, Rudrapatna, Venkatesh, Daniels, Gregory, Taback, Bret, Aung, Sandra, Lowder, James, Lawson, David
Publicado 2014

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma

por van Herpen, Carla M.L., Agarwala, Sanjiv S., Hauschild, Axel, Berking, Carola, Beck, J. Thaddeus, Schadendorf, Dirk, Jansen, Rob, Queirolo, Paola, Ascierto, Paolo A., Blank, Christian U., Heinrich, Michael C., Pal, Rupam R., Derti, Adnan, Antona, Victor, Nauwelaerts, Heidi, Zubel, Angela, Dummer, Reinhard
Publicado 2019

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

por Masucci, Giuseppe V., Cesano, Alessandra, Eggermont, Alexander, Fox, Bernard A., Wang, Ena, Marincola, Francesco M., Ciliberto, Gennaro, Dobbin, Kevin, Puzanov, Igor, Taube, Janis, Wargo, Jennifer, Butterfield, Lisa H., Villabona, Lisa, Thurin, Magdalena, Postow, Michael A., Sondel, Paul M., Demaria, Sandra, Agarwala, Sanjiv, Ascierto, Paolo A.
Publicado 2017

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)

por Ascierto, Paolo A., Agarwala, Sanjiv S., Botti, Gerardo, Budillon, Alfredo, Davies, Michael A., Dummer, Reinhard, Ernstoff, Marc, Ferrone, Soldano, Formenti, Silvia, Gajewski, Thomas F., Garbe, Claus, Hamid, Omid, Lo, Roger S., Luke, Jason J., Michielin, Oliver, Palmieri, Giuseppe, Zitvogel, Laurence, Marincola, Francesco M., Masucci, Giuseppe, Caracò, Corrado, Thurin, Magdalena, Puzanov, Igor
Publicado 2019

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)

por Ascierto, Paolo A., Agarwala, Sanjiv S., Warner, Allison Betof, Ernstoff, Marc S., Fox, Bernard A., Gajewski, Thomas F., Galon, Jérôme, Garbe, Claus, Gastman, Brian R., Gershenwald, Jeffrey E., Kalinski, Pawel, Krogsgaard, Michelle, Leidner, Rom S., Lo, Roger S., Menzies, Alexander M., Michielin, Olivier, Poulikakos, Poulikos I., Weber, Jeffrey S., Caracò, Corrado, Osman, Iman, Puzanov, Igor, Thurin, Magdalena
Publicado 2023

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)

por Ascierto, Paolo A., Puzanov, Igor, Agarwala, Sanjiv S., Bifulco, Carlo, Botti, Gerardo, Caracò, Corrado, Ciliberto, Gennaro, Davies, Michael A., Dummer, Reinhard, Ferrone, Soldano, Gajewski, Thomas F., Garbe, Claus, Luke, Jason J., Marincola, Francesco M., Masucci, Giuseppe, Mehnert, Janice M., Mozzillo, Nicola, Palmieri, Giuseppe, Postow, Michael A., Schoenberger, Stephen P., Wang, Ena, Thurin, Magdalena
Publicado 2018